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Nineteen patients survived a cardiac arrest not associ-
ated with an acute myocardial infarction, and had a
normal electrophysiologic study with no inducible ven-
tricular tachycardia despite programmed stimulationwith
one to three extrastimuli at two or more ventricular sites.
Among 14 patients who had obstructive coronary artery
disease, cardiac arrest occurred during exertion or an
episode of angina pectoris in 11; 24 hour ambulatory
electrocardiographic recordings demonstrated infre-
quent or no premature ventricular complexes in 10 and
an ischemicresponse occurred during stage I or II (Bruce
protocol) in 6 of 9 patients who underwent exercise test-
ing. Treatment of these patients consisted of myocardial
revascularization (eight patients) or antianginal medi-
cations (sixpatients). Only three patients were alsotreated
with an antiarrhythmic drug. Over a follow-up period
of 26 ± 15 months (mean ± standard deviation), only
one patient died suddenly.
Two patients who had coronary artery spasm were
Ventricular tachycardia can be induced by programmed ven-
tricular stimulation in the majority of patients who survive
an out of hospital episode of cardiac arrest unassociated
with an acute myocardial infarction (1-5). Long-term an-
tiarrhy thmic drug treatment of these patients guided by the
results of electropharmacologic testing has been associated
with a low incidence of sudden death (1,3-5).
In contrast, of the patients who survive a cardiac arrest
with documented ventricular tachycardia or ventricular fi-
brillation at the time of resuscitation, 12 to 37% do not have
inducihie ventricular tachycardia or ventricular fibrillation
during electrophysiologic testing (1-5). The prognosis in
these patients is unclear. Although some investigators (1,3,6)
have reported that such patients have an excellent prognosis
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treated with coronary vasodilator medications and had
no recurrence of cardiac arrest over 7 and 36 months
of follow-up, respectively. Three patients who had car-
diomyopathy or no identifiable structural heart disease
were treated with nadolol or amiodarone and had no
recurrence of cardiac arrest over 3 to 27 months of fol-
low-up.
Among patients who survive a cardiac arrest and
have a normal electrophysiologic study, those with ob-
structive coronary artery diseaseor coronary artery spasm
generally have an excellent prognosis with treatment di-
rected primarily at the underlying heart disease. The
clinical features of these patients suggest that cardiac
arrest was related to ischemia rather than a primary
arrhythmia. The natural history of patients with a car-
diomyopathy or no identifiable structural heart disease
who survive a cardiac arrest and have a normal elec-
trophysiologic study remains to be determined.
without specific antiarrhythmic drug therapy but with treat-
ment of the underlying heart disease, others (4,7) have re-
ported that 32 to 50% of these patients die suddenly, either
with or without antiarrhythmic drug treatment.
The purpose of this study is to describe the clinical fea-
tures and prognosis of patients who survived an isolated
episode of cardiac arrest and who did not have inducible
ventricular tachycardia or other abnormalities during elec-
trophysiologic testing.
Methods
Patients. Between June 1979 and August 1983, 96 pa-
tients underwent an electrophysiologic study at Moffitt Hos-
pital because of one or more episodes of out of hospital
cardiac arrest. Nineteen of these 96 patients who had no
demonstrable abnormalities during electrophysiologic test-
ing are the subjects of this report.
All 19 patients had a history of a cardiac arrest with
sudden collapse and complete loss of consciousness that
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required cardiopulmonary resuscitation. In all patients, the
cardi ac rhythm at the time of direct current countershock
was ventricular fibrillation or ventricular flutter. Although
16 of the 19patients had mild elevation of the serum creatine
kinase MB fraction, none had electrocardiographic evidenc e
of an acute myocardial infarction (new Q waves or persistent
ST segment/T wave abnormalitie s). In addition , no patient
had myocardial uptake on a technet ium pyrophosphate myo-
cardial scintigram performed I to 3 days after the cardiac
arrest.
The f ollowing exclusionary criteria were applied in se-
lecting patients for this study: I) a high suspicion of drug-
induced ventricular tachycardia , that is, cardiac arrest oc-
curring in a patient treated with a type I antiarrhythmic drug,
with recurrent episodes of ventricul ar tachycardia of the
"torsade de pointes" type (8) and a prolonged QT interval;
2) cardiac arrest associated with a metabolic abnormality:
and 3) cardiac arrest occurring as a termin al event in patients
with cardiogenic shock . Because our intent was to evaluate
patients with an isolated episode of cardiac arrest. we also
excluded patients with documented ventricular tachycard ia
in whom ventricular fibrillation was caused by a recurrent
episode of ventricular tachycardia.
Noninvasive studies. The patient s were evaluated I to
6 weeks after their cardiac arrest. An exercise treadmill test
(Bruce protocol) was performed in 14 patients (with thal-
lium-20 I scintigraphy in 12); 5 patients did not undergo
treadmill testing becau se of unstable angina or the inability
to perform upright exercise . An ischemic response to ex-
ercise testing was defined as I mm or greater horizontal ST
segment depression at 80 ms after the J point or a perfusion
defect with redistribution on delayed scintigrams obtained
2 to 3 hours after the exercise study.
Continuous electrocardiographic monitoring in the ab-
sence of antiarrhythmic drug therapy was performed for at
least 24 hours in all patients. The following classification
system, described by Lown and Wolf (9), was used to grade
premature ventricular complexes: grade 0 = no premature
ventricular complexes; grade I = less than 30 premature
ventricular complexes per hour ( IA = less than I per min-
ute; IB = more than I per minute ); grade 2 = more than
30 premature ventricular compl exes per hour ; grade 3 =
multiform premature ventricular complexes; grade 4 = re-
petit ive premature ventricular complexes (4A = ventricular
couplets; 4B = three or more consecutive premature ven-
tricul ar complexes); and grade 5 = early premature ven-
tricular complexes (R on T ). A two-dimensional echocar-
diogram was performed in all patients.
Cardiac catheterization. All patients, with the excep-
tion of one who refused , underwent cardiac catheterization
includ ing left ventricular and coronary angiography. An
ergonovine provocation test (10) was performed if obstruc-
tive coronary artery lesions were not seen on the coronary
angio grams.
Electrophysiologic testing. Five patients who had se-
vere coronary artery disease underwent uneventful coronary
artery bypass graft surgery 7 to 10 days before electro-
physiologic testing . One patient underwent electrophysio-
logic testing before and after bypass surgery (with both
studies being negati ve). Electrophysiologic testing was per-
formed with the patient in the fasting unsedated state after
informed written consent was obtained, at least five half-
lives after discontinu ation of antiarrhythmic drugs . Pacing
stimuli were twice diastol ic threshold in the first five patient s
studied and 5 rnA in subsequent patients . The stimuli were
2 ms in duration and were delive red by a programmable
stimulator (Bloom Associates).
The following stimulation protocol was used. Overdrive
pacing was performed for 5 to 10 seconds at cycle length s
of 500 to 250 ms. Programmed ventricular stimulation was
performed with one, two and three ventricular extrastimuli
at drive trains of 500 and 400 ms. The stimulation protocol
was performed initially at the apex of the right ventricle .
In all patients, the stimulation protocol was then repeated
at one or more additi onal ventricular sites (right ventricular
outflow tract in five patients, left ventricular apex in eight
patient s and both the right ventricular outflow tract and left
ventricular apex in six patients). In the five patients who
did not have obstructi ve coronary artery disease, the stim-
ulation protocol was repeated at one or two ventricular sites
during a continuous infusion of isoproterenol, titrated to
maintain a heart rate of 120 beats/min.
Sustained ventricular tachycardia was defined as ven-
tricular tachycardia lasting at least 30 seconds or requ iring
electrical cardioversion . Nonsustained ventricular tachy-
cardia was defined as ventricular tachycardia six beats to
30 second s in duration. No patient in this study had inducible
sustained or nonsustained ventricular tachycardia. In 17 of
the patients, one to five repetitive ventricular complexes
were induced .
The electrophysiologic testing protocol also included
measurement of the sinus node recovery time , assessment
of atrioventricular conduction and attempts to induce supra-
ventricular tachycardia . Results of testing were noncontri -
butory in all patient s.
Follow-up. The patients were followed up by either one
of us or the referrin g physicians. A 24 hour ambulatory
electrocardiographic recording was obtained every 3 to 6
months. Sudden death was defined as unexpected death from
natural causes occurring within I hour of the patient' s collapse .
Results
Patients With Obstructive Coronary Artery Disease
Clinical features. There were 12 men and 2 women with
a mean age of 62 ± 12 years (mean ± standard deviation)
(Table I). Twelve of the 14 patients had a known history
JACC Vol I, No.1
July 1984:'>-44
MORADY ET AL.
CARDIAC ARREST AND NORMAL ELECTROPHYSIOLOGIC STUDY
41
of angina pectoris or myocardial infarction, or both. None
had undergone coronary artery bypass graft surgery before
cardiac arrest. Only two patients had overt congestive heart
failure. At the time of cardiac arrest, seven patients were
being treated with propranolol (80 to 160 mg/day) and ni-
trates for angina pectoris, and one was being treated with
procainamide (1.5 g/day) because of frequent premature
ventricular complexes.
Cardiac arrest occurred during strenous exertion (bicy-
cling, running or carrying a heavy package) in seven patients
and during mild exertion (walking) in one. These patients
all had retrograde amnesia and did not recall whether they
experienced chest pain before the cardiac arrest. In an ad-
ditional three patients, the cardiac arrest was preceded by
chest pain typical of angina pectoris, occurring at rest or
during minimal exertion.
Catheterization findings (Table 1). Among the 13 pa-
tients who underwent coronary angiography, 2 had a sig-
nificant (> 70%) stenosis of the left main coronary artery,
7 had triple vessel disease, 3 had double vessel disease and
only I had single vessel disease. The mean left ventricular
ejection fraction (determined by contrast left ventriculog-
raphy III 13 patients and radionuclide angiography in 1) was
0.50 ::: 0.19. Thirteen patients had one or more ventricular
wall motion abnormalities; nine of these patients had a dis-
crete ventricular aneurysm.
Electrocardiographic findings (Table 1). The 24 hour
ambulatory electrocardiographic recording demonstrated grade
oor I premature ventricular complexes in 10 patients and
grade 2 or 3 premature ventricular complexes in 4 patients.
An ischemic response occurred in all nine patients who
underwent an exercise treadmill test. During exercise, one
patient developed sustained ventricular tachycardia that re-
quired electrical cardioversion and only two other patients
had an increase in grade of premature ventricular complexes
above the baseline value.
Follow-up (Table 2). The mean duration of follow-up
was 26 ± 15 months. Seven patients underwent coronary
artery bypass graft surgery and one patient underwent per-
cutaneous transluminal coronary angioplasty. These patients
were not treated with antiarrhythmic drugs; none has had a
recurrence of cardiac arrest and all remain alive and well,
except for one patient who died of pneumonia. Two patients
who had frequent premature ventricular complexes were
treated with either procainamide or encainide in addition to
antianginal medications. Follow-up Holter monitor record-
ings demonstrated greater than 85% suppression of pre-
mature ventricular complexes in both. The patient who was
being treated with encainide died suddenly after a heated
argument at IS months of follow-up. A nitroglycerin tablet
was found in his hand; an autopsy was not performed. The
remaining four patients were treated with antianginal med-
ications and have remained well without a recurrence of
cardiac arrest. Only one of the latter patients was also treated
empirically with an antiarrhythmic drug (amiodarone) at the
request of his referring physician.
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Patients Without Obstructive Coronary
Artery Disease
Clinical findings (Table 1). There were four men and
one woman who did not have coronary artery disease. Their
mean age ( ± standard deviation ) was 53 ± 12 years. Two
patients had a positive ergonovine provocation test for focal
coronary artery spasm, one patient had a nonobstructi ve
hypertrophic cardiomyopathy, one had conge stive cardio -
myopathy and one had no demonstrable structural heart
disease. The left ventricular ejection fraction was normal in
all patients, except one who had congestive cardiomyopathy
and an ejection fraction of 0 .32.
The cardiac arrest in both patient s who had coronary
artery spasm was preceded by chest pain that occurred in
one patient during running and in the other while at rest.
In the other three patients, the cardiac arrest occurred during
rest or minimal exertion. One patient was being treated with
quinidine at the time of the card iac arrest because of frequent
premature ventricular complexes .
Electrocardiographic findings (Table 1). Three pa-
tients had no premature ventricular complexes (grade 0)
dur ing a 24 hour ambulatory electrocardiographic recording,
while one had frequent grade 2 and one had grade 4 pre-
mature ventricular complexes (Table I ).
The patient with coronary artery spasm who had chest
pain and cardiac arrest while running had an ischemic re-
sponse during exerci se testing, but no ventricular ectopic
activity. The other four patients did not have chest pain or
ST segment abnormalities during the exercise treadmill test.
The premature ventricular compl ex grade was greater during
exercise than at baseline in only one of the five patients.
Follow-up (Table 2). The mean follow-up period was
16 ± 15 months in these five patients. The two patients
who had coronary artery spasm were treated with a calcium
channel blocking agent, in addit ion to propafenone in the
patient who had frequent premature ventricular complexes.
The other three patient s were treated empirically with na-
dolol or arniodaron e. All have remained well without a
recurrence of cardiac arrest.
Discussion
Prognosis. Fourteen of the 19 patients in this series who
survived cardiac arrest and had a normal electrophysiologic
study had coronary artery disease. Only 3 of the 14 were
treated with an antiarrhythmic drug; the others either under -
went coronary artery bypass graft surgery or were treated
with antianginal medications. Only 1 of the 14 patients died
suddenly over a mean follow-up period of 26 months. These
findings demonstrate that patients with corona ry artery dis-
ease who survive a cardiac arrest and have a negat ive elec-
trophysiologic study may have an excellent prognosis with
treatment directed only toward the coronary artery disease
and do not necessarily require specific antiarrhythmic drug
therapy .
These results confirm the prelim inary findings of Tom-
maso et al. (6) , who reported that 16 survivors of cardiac
arrest who did not have inducible ventricular tachycardia
and were treated only with bypass surgery or beta-adrenergi c
blocking agents had no recurren ce of cardiac arrest over 14
Table 2. Treatment and Follow-up of 19 Patients Who Survived Cardiac Arrest and Had a Normal Electrophysiologic Study
Case
Revascularization
Procedure
Drug Therapy
Antianginal Antiarrhythmic
Follow-up
(mo)
1
2
3
4
5
6
7
8
9
10
II
12
13
14
15
16
17
18
19
CABG
CABG
CABG
CABG
CABG
CABG
PTCA
CABG
Nadolol, nitrates
Nifedipine, nitrates
Nadolol, nitrates
Propranolol. nitrates
Nitrates
Propranolol, nitrates
Nifedipine
Verapamil
Procainamide
Encainide
Amiodarone
Propafenone
Amiodarone
Amiodarone
Nadolol
54
47
45
39
31
27
26 (died of pneumonia)
24
20
15 (sudden death)
14
14
6
5
36
17
5
3
27
CABG = coronary artery bypass grafting; PTCA = percutaneous transluminal coronary angioplasty.
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months of follow-up. In addition, our results confirm an
earlier report from our laboratory (3) in which seven patients
who had coronary artery disease and no inducible ventricular
tachycardia had no recurrence of cardiac arrest with con-
ventional treatment of the coronary disease. Ruskin et al.
(I) also reported that two patients with coronary artery dis-
ease who survived cardiac arrest and had no inducible ven-
tricular tachycardia did well after bypass surgery, without
antiarrhythmic drug therapy.
In contrast, Roy et al. (7) reported that survivors of
cardiac arrest who did not have inducible sustained ven-
tricular tachycardia did not have a good prognosis, with a
32% incidence of sudden death over a mean follow-up pe-
riod of 20 months. However, in their preliminary report,
Roy et al. did not report results in the subgroup of patients
with coronary artery disease. In addition, although their
patients did not have sustained ventricular tachycardia, many
may have had inducible nonsustained ventricular tachy-
cardia. In our study and the studies mentioned earlier (1,6),
the patients had neither inducible sustained nor nonsustained
ventricular tachycardia. Inducible nonsustained ventricular
tachycardia may have different prognostic implications than
no inducible ventricular tachycardia .
Role of coronary artery disease and ischemia. Our
patients with coronary artery disease showed the following
general characteristics: I) the coronary artery disease was
usually severe, with 9 of 13 patients who underwent cardiac
catheterization having disease of the left main coronary ar-
tery or triple vessel disease; 2) all the patients who under-
went treadmill testing had an ischemic response in stage I,
II or III (Bruce protocol); and 3) 10 of the 14 patients were
engaged in strenuous activity or experienced angina pectoris
at rest at the time of the cardiac arrest. Because of retrograde
amnesia, it is not known whether the remaining patients had
angina at the time of their cardiac arrest. These general
characteristics, in association with the finding of a negative
electrophysiologic study, suggest that the cardiac arrest in
these patients was caused by ventricular tachycardia or ven-
tricular fibrillation, precipitated by transient ischemia. The
finding of noninducible ventricular tachycardia after cardiac
arrest suggests that the substrate for reentry was not present
at the time of electrophysiologic testing . It may be that the
appropriate electrophysiologic milieu for ventricular tachy-
cardia or ventricular fibrillation to occur in these patients
was dependent on the presence of myocardial ischemia. This
possibility is supported by the finding that our patients with
coronary artery disease and a negative electrophysiologic
study had an excellent prognosis when treatment was di-
rected only toward the prevention of myocardial ischemia .
Benditt et al. (4) reported that of two patients with coro-
nary artery disease who survived a cardiac arrest and had a
negati \ e electrophysiologic study , one died suddenly despite
undergoing coronary artery bypass surgery and treatment
with propranolol. In addition, I of our 14 patients died
suddenly despite treatment with antianginal medications.
Therefore. a negative electrophysiologic study in patients
with coronary artery disease does not guarantee a benign
prognosis . It may be that the patients who died suddenly in
our series and in the series of Benditt et al. (4) had a re-
currence of myocardial ischemia, which precipitated a ma-
lignant ventricular arrhythmia. Consistent with this possi-
bility is that our patient who died suddenly was found with
a nitroglycerin tablet in his hand, suggesting that his death
may have been preceded by angina pectoris.
Role of myocardial revascularization. Garan et al. (II)
reported that among 17 patients with coronary artery disease
who had cardiac arrest or ventricular tachycardia, ventric-
ular tachycardia was inducible in 15 patients before myo-
cardial revascularization but in only 7 patients after revas-
cularization. This finding demonstrates that treatment of
myocardial ischemia alone may eliminate the potential for
ventricular tachycardia or ventricular fibrillation in some
patients with coronary artery disease . Five of our patients
underwent electrophysiologic testing only after having
undergone myocardial revascularization . The findings of
Garan et al. (II) suggest that some of these patients may
have had inducible ventricular tachycardia or ventricular
fibrillation before myocardial revascularization. However,
the one patient in our study who underwent electrophysi-
ologic testing both before and after myocardial revascular-
ization did not have inducible ventricular tachycardia during
either study .
Role of exercise. Although all of our patients with coro-
nary artery disease who underwent treadmill testing had an
ischemic response, only one developed sustained ventricular
tachycardia. It may be that ventricular tachycardia or ven-
tricular fibrillation did not occur during exercise in the re-
maining patients because the testing was stopped as soon
as signs or symptoms of ischemia occurred. In addition, the
development of ventricular tachycardia or ventricular fi-
brillation in patients who experience myocardial ischemia
during exercise may depend on the chance occurrence of
premature ventricular complexes that provide the appropri-
ate trigger for the ventricular tachycardia or ventricular
fibrillation.
Role of coronary spasm. Although 5 of the 19 patients
in this study did not have coronary artery disease, myo-
cardial ischemia could be implicated as a causal factor of
cardiac arrest in an additional 2 of these 5 patients as a
result of artery spasm . These patients have had no recurrence
of cardiac arrest (or chest pain) while being treated with
calcium channel blocking agents .
Role of cardiomyopathy. The remaining three patients
in this series had either a hypertrophic cardiomyopathy,
congestive cardiomyopathy or no demonstrable structural
heart disease. In these patients, no potential precipitant of
cardiac arrest could be identified . Although subendocardial
ischemia may theoretically occur in patients with cardio-
44 MORADY ET AL.
CARDIAC ARRESTAND NORMAL ELECTROPHYSIOLOGIC STUDY
JACC Vol. 4. No.1
July 1984:39-44
myopathy who do not have coronary artery disease, these
patients did not demonstrate any signs or symptoms of is-
chemia during exercise testing. Because no potentially re-
mediable precipitant of cardiac arrest was identifiable and
because of the fear of a recurrence of cardiac arrest, these
patients were treated empirically with amiodarone or na-
dolol. The natural history of patients with cardiomyopathy
or without identifiable structural heart disease who survive
cardiac arrest and have a negative electrophysiologic study
remains unknown.
Role of antiarrhythmic drugs. Graboys et al. (12) re-
ported that the abolition of advanced grades of premature
ventricular complexes with antiarrhythmic drugs in patients
who had ventricular fibrillation or ventricular tachycardia
provided a high degree of protection against sudden death.
Of note is that only 9 of 19 patients in our study had ad-
vanced grades of premature ventricular complexes (grades
2 to 5) during ambulatory electrocardiographic recordings
or exercise testing. Therefore, the technique of premature
ventricular complex suppression described by Graboys et
al. would not have been applicable in a large proportion of
patients in this series. The one patient in our study who died
suddenly had frequent premature ventricular complexes and
couplets, with more than 90% suppression by encainide.
Therefore, in the subgroup of patients with coronary artery
disease who do not have inducible ventricular tachycardia,
suppression of premature ventricular complexes may not
protect against sudden death.
The stimulation protocol used in our study was an ag-
gressive one that included the use of triple ventricular ex-
trastimuli and stimulation at multiple ventricular sites. The
use of triple extrastimuli and multiple ventricular sites in-
creases the yield of programmed ventricular stimulation.
Therefore, our results may not apply to patients who undergo
electrophysiologic testing with a less aggressive stimulation
protocol.
Conclusion. Electrophysiologic testing plays an impor-
tant role in the evaluation of patients who have survived
cardiac arrest. A normal electrophysiologic study appears
to identify those patients with coronary artery disease who
generally have an excellent prognosis with treatment di-
rected primarily at the prevention of ischemia. In contrast,
as prior studies (1,3,4) have demonstrated, the finding of
inducible ventricular tachycardia indicates the need for spe-
cific antiarrhythmic therapy in addition to treatment of the
underlying heart disease.
In the subgroup of patients who survive cardiac arrest
and do not have coronary artery disease, electropharma-
cologie testing can be performed if ventricular tachycardia
is inducible. In those who do not have inducible ventricular
tachycardia, specific recommendations cannot be made re-
garding the need for long-term antiarrhythmic drug therapy.
Because of the fear of recurrent cardiac arrest. we have
treated these patients empirically with antiarrhythmic drugs;
their natural history remains unclear.
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